Financials
- Market Capitalization 28.75 M
- Employee 40
- Founded 2015
- CEO N/A
- Website www.nextcure.com
- Headquarter Delaware, United States
- FIGI BBG00BTH5153
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.72
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4351 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.00 USD | -5.66% | -10.71% | -23.66% | -3.85% | 31.44 M USD | ||
| 4365 | CVM Cel-Sci Corporation Common Stock | 1.74 USD | -6.95% | -37.18% | +14.47% | -66.21% | 30.60 M USD | ||
| 4381 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.68 USD | +3.07% | -5.62% | +1.82% | -82.33% | 28.44 M USD | ||
| 4388 | IGC IGC Pharma, Inc. Common Stock | 0.27 USD | -3.57% | -3.57% | -3.57% | +5.39% | 27.91 M USD |